MedTrace Logo

High Frequency Chest Wall Oscillation in Chronic Obstructive Pulmonary Disease (COPD)

NCT00863616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2009-03-18

No results posted yet for this study

Summary

Patients with Chronic obstructive pulmonary disease (COPD) tend to have cough, excess mucus production and breathlessness as cardinal features. The excess mucus production often leads to frequent infections, exacerbations and poor quality of life. Mucociliary clearance may have an impact on improving symptoms, exercise tolerance, quality of life and reduce exacerbations.

High frequency chest wall oscillation(HFCWO) devices use percussion to the chest wall delivered from a pump through a close fitting inflatable vest. This technique has been shown to enhance mucus clearance in patients with cystic fibrosis and Bronchiectasis. This pilot study was designed to explore the feasibility, tolerance and effectiveness of the HFCWO in patients with advanced COPD.

Conditions

Interventions

DEVICE

HFCWO - SmartVest

SmartVest with vest administered for 20min at 11-13Hz

Sponsors & Collaborators

  • Electromed, Inc.

    collaborator INDUSTRY

  • East and North Hertfordshire NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Indranil Chakravorty, PhD, MRCP · East & North Herts NHS Trust, Stevenage, Herts, UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00863616 on ClinicalTrials.gov